Myriad Genetics (MYGN) Income Statement

Click line-items for a historical chart and %

Molecular diagnostic testing	165.1M
Companion diagnostic services	12.4M
Total revenue	177.5M
Cost of molecular diagnostic testing	34.3M
Cost of companion diagnostic services
Research and development expense	19.4M
Selling, general, and administrative expense	111.9M
Total costs and expenses	171.3M
Operating income	6.2M
Interest income	300K
Other
Total other income
Income from continuing operations before income taxes	4M
Income tax provision (benefit)	5.2M
Net income	-1.2M
Continuing operations
Discontinued operations
Earnings per basic share	-0.02
Continuing operations
Discontinued operations
Earnings per diluted share	-0.02
Basic	68.8M
Diluted	68.8M

Entities mentioned with MYGN

View All Entities